West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. (WST)

Market Open
5 Dec, 18:02
NYSE NYSE
$
279. 87
-1.9
-0.67%
$
19.95B Market Cap
49.01 P/E Ratio
0.8% Div Yield
8,644 Volume
7.62 Eps
$ 281.77
Previous Close
Day Range
278.26 283.52
Year Range
187.43 348.9
Want to track WST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 69 days
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
12 Feb 2026 (In 2 months)
1.83
Cons. EPS
-
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
23 Oct 2025
1.68
Cons. EPS
1.96
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
23 Jul 2025
1.51
Cons. EPS
1.84
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
23 Apr 2025
-
Cons. EPS
-
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
13 Feb 2025
1.71
Cons. EPS
1.82
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
24 Oct 2024
1.5
Cons. EPS
1.85
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
25 Jul 2024
1.74
Cons. EPS
1.52
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
25 Apr 2024
1.26
Cons. EPS
1.56
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
15 Feb 2024
1.78
Cons. EPS
1.83
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
26 Oct 2023
1.86
Cons. EPS
2.16
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
27 Oct 2016
0.53
Cons. EPS
0.53
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
28 Jul 2016
0.56
Cons. EPS
0.59
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
28 Apr 2016
0.51
Cons. EPS
0.53
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
18 Feb 2016
0.47
Cons. EPS
0.47
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
29 Oct 2015
0.43
Cons. EPS
0.44
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
30 Jul 2015
0.45
Cons. EPS
0.47
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
30 Apr 2015
0.4
Cons. EPS
0.45
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
19 Feb 2015
0.46
Cons. EPS
0.45
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
30 Oct 2014
0.43
Cons. EPS
0.44
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
31 Jul 2014
0.47
Cons. EPS
0.52
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
1 May 2014
0.41
Cons. EPS
0.38
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
20 Feb 2014
0.38
Cons. EPS
0.38
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
31 Oct 2013
0.36
Cons. EPS
0.39
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
1 Aug 2013
0.41
Cons. EPS
0.43
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
2 May 2013
0.43
Cons. EPS
0.44
EPS
West Pharmaceutical Services, Inc. logo
WST West Pharmaceutical Services, Inc.
21 Feb 2013
0.28
Cons. EPS
0.31
EPS

WST Earnings Reports FAQ

What is the earnings per share (EPS) for WST?

The current EPS is 7.62.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately 16.61%, reflecting the WST's performance and NYSE market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-12, based on the WST's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 1.96 per share, reported on 2025-10-23. For dividend history, visit the WST Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 142.79, calculated based on the most recent stock price of $279.87.